Brain-Triggered zaps: new hope for stroke arm weakness?

NCT ID NCT07088107

Recruiting now Disease control Sponsor: The Hong Kong Polytechnic University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device that uses brain signals to time magnetic pulses for stroke rehabilitation. The device reads blood flow changes in the brain and fires a magnetic pulse at the right moment to boost brain activity. Researchers will first test the system in healthy adults, then in 20 stroke survivors to see if it improves arm movement and brain excitability.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fNIRS-triggered transcranial magnetic stimulation (TMS) device
What this could lead to: If successful, this could lead to a more personalized and effective brain stimulation therapy for stroke survivors, improving arm and hand movement.
What could go wrong: This is a very small, early-stage study (20 people) focused on testing the system's accuracy, not yet proving it works for recovery. The approach is complex and may not translate to real-world benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC SUBCORTICAL STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STROKE

Contacts and locations

Locations

Hong Kong Polytechnic University
NOT_YET_RECRUITING

Hong Kong, 000000, Hong Kong
Hong Kong Polytechnic University - Brain Stimulation Laboratory
RECRUITING

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.